Peripheral Arterial Disease in the Elderly Recognition and Management

被引:21
作者
Aronow, Herbert [1 ]
机构
[1] St Joseph Mercy Hosp, Michigan Heart & Vasc Inst, Clin Scholars Program, Ann Arbor, MI 48104 USA
关键词
D O I
10.2165/0129784-200808060-00002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Peripheral arterial disease (PAD) is a common but frequently overlooked vascular disease, often affecting the lower extremities. The prevalence of PAD increases exponentially with age, and this is of particular concern among the elderly population because this condition frequently signals disease in other vascular beds, including the coronary arteries and/or cerebral vasculature. In addition to the increased risk of cardiovascular disease and stroke, patients with PAD may also experience functional impairment and decreased quality of life. The ankle-brachial index is the most effective and widely used screening tool for detecting PAD and should be performed when PAD is suspected, based on the medical history or physical examination. Current treatment guidelines recommend risk factor modification, including exercise therapy and smoking cessation interventions, combined with pharmacologic measures for secondary prevention and management of symptoms of PAD. Antiplatelet therapy is an integral component of global cardiovascular risk reduction strategies in patients with PAD. Current guidelines provide a significant opportunity for practitioners to detect and treat patients with PAD in a timely and effective manner, thereby improving the overall mortality, morbidity, and quality of life associated with this disease.
引用
收藏
页码:353 / 364
页数:12
相关论文
共 94 条
  • [1] Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease
    Aronow, WS
    Ahn, C
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (11) : 1284 - 1286
  • [2] Frequency of new coronary events in older persons with peripheral arterial disease and serum low-density lipoprotein cholesterol ≥ 125 mg/dl treated with statins versus no lipid-lowering drug
    Aronow, WS
    Ahn, C
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (07) : 789 - +
  • [3] Effect of Simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatment
    Aronow, WS
    Nayak, D
    Woodworth, S
    Ahn, C
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (06) : 711 - 712
  • [4] Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
  • [5] Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication
    Bendermacher, B. L. W.
    Willigendael, E. M.
    Teijink, J. A. W.
    Prins, M. H.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (02):
  • [6] Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
    Bhatt, DL
    Fox, KAA
    Hacke, W
    Berger, PB
    Black, HR
    Boden, WE
    Cacoub, P
    Cohen, EA
    Creager, MA
    Easton, JD
    Flather, MD
    Haffner, SM
    Hamm, CW
    Hankey, GJ
    Johnston, SC
    Mak, KH
    Mas, JL
    Montalescot, G
    Pearson, TA
    Steg, PG
    Steinhubl, SR
    Weber, MA
    Brennan, DM
    Fabry-Ribaudo, L
    Booth, J
    Topol, EJ
    Frye, RL
    Amarenco, P
    Brass, LM
    Buyse, M
    Cohen, LS
    DeMets, DL
    Fuster, V
    Hart, RG
    Marler, JR
    McCarthy, C
    Schoemig, A
    Lincoff, AM
    Brener, SJ
    Sila, CA
    Albuquerque, A
    Aroutiounov, G
    Artemiev, D
    Atkeson, BG
    Bartel, T
    Basart, DCG
    Lima, AB
    Belli, G
    Bordalo e Sa, AL
    Bosch, X
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (16) : 1706 - 1717
  • [7] International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis
    Bhatt, DL
    Steg, PG
    Ohman, EM
    Hirsch, AT
    Ikeda, Y
    Mas, JL
    Goto, S
    Liau, CS
    Richard, AJ
    Röther, J
    Wilson, PWF
    Andersen-Dalheim, H
    Anderson, P
    Anell, B
    Arber, S
    Armstrong, K
    Arnot, D
    Baldam, A
    Barratt, I
    Barresi, S
    Beder, J
    Benson, M
    Bergman, F
    Best, J
    Bhasim, R
    Bovell, G
    Bowman, N
    Brkic, M
    Bromberger, D
    Brown, D
    Brown, J
    Brownstein, M
    Bruce, A
    Buonopane, J
    Burns, S
    Butler, A
    Byrne, D
    Carson, J
    Cassimatis, P
    Chaffey, G
    Chambers, D
    Chan, WJ
    Chan, B
    Cheatham, J
    Chen, R
    Cheong, B
    Cheung, C
    Chin, J
    Chiu, A
    Choo, E
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (02): : 180 - 189
  • [8] Projection of diabetes burden through 2050 - Impact of changing demography and disease prevalence in the US
    Boyle, JP
    Honeycutt, AA
    Narayan, KMV
    Hoerger, TJ
    Geiss, LS
    Chen, H
    Thompson, TJ
    [J]. DIABETES CARE, 2001, 24 (11) : 1936 - 1940
  • [9] Impact of cholesterol reduction on peripheral arterial disease in the Program on the Surgical Control of the Hyperlipidemias (POSCH)
    Buchwald, H
    Bourdages, HR
    Campos, CT
    Nguyen, P
    Williams, SE
    Boen, JR
    [J]. SURGERY, 1996, 120 (04) : 672 - 679
  • [10] Management of peripheral arterial disease in primary care
    Burns, P
    Gough, S
    Bradbury, AW
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2003, 326 (7389): : 584 - 588